ResearchMoz

Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2013-04-23
No. Of Pages » 115
 
 
   
 The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period. 
   
 This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
3.3.1 Regulatory Support
3.3.2 Increasing Food Demand 
3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
3.4.1 Ethical Issues Associated with Clinical Trials
3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
3.5.1 Emergence of Biosimilars
3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat from Substitutes
3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
4.2.1 Biopharmacy
4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
4.2.2 Bioservices
4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
4.2.3 Bioagriculture
4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
4.2.4 Bioindustrial
4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)

Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
5.5 Nanobiotechnology
5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
5.6 Chromatography
5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
5.7 Dna Sequencing Technology
5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
5.8 Cell Based Assay
5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)

Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
6.3 Europe
6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
6.5 Rest Of World
6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)

Chapter 7 Company Profile
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Swot Analysis
7.1.5 Recent Developments
7.2 Amgen Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.2.4 Swot Analysis
7.2.5 Recent Developments
7.3 Glaxosmithkline
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.3.4 Swot Analysis
7.3.5 Recent Developments
7.4 Johnson And Johnson
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategy.
7.4.4 Swot Analysis
7.4.5 Recent Developments
7.5 Merck
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
7.5.4 Swot Analysis
7.5.5 Recent Developments
7.6 Novartis
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategy
7.6.4 Swot Analysis
7.6.5 Recent Developments
7.7 Novo Nordisk
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies.
7.8.4 Swot Analysis
7.8.5 Recent Developments
7.9 Roche
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Swot Analysis
7.9.5 Recent Developments
7.10 Sanofi - Aventis
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Swot Analysis
7.10.5 Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategy
7.11.4 Swot Analysis
7.11.5 Recent Developments
7.12 Biogen Idec Inc
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategy
7.12.4 Swot Analysis
7.12.5 Recent Developments
7.13 Astra Zeneca
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategy
7.13.4 Swot Analysis
7.13.5 Recent Developments
7.14 Genentech
7.14.1 Company Overview
7.14.2 Financial Overview
7.14.3 Business Strategies
7.14.4 Swot Analysis
7.14.5 Recent Developments
7.15 Genzyme
7.15.1 Company Overview
7.15.2 Financial Overview
7.15.3 Swot Analysis
7.15.4 Recent Developments
7.16 Gilead Sciences
7.16.1 Company Overview
7.16.2 Financial Overview
7.16.3 Swot Analysis
7.16.4 Business Strategies
7.16.5 Recent Developments
7.17 Celgene
7.17.1 Company Overview
7.17.2 Financial Overview
7.17.3 Business Strategy
7.17.4 Swot Analysis
7.17.5 Recent Developments

List of Tables


Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

List of Figures


Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

Upcoming Reports:

Poland: market of cago containers for vehicles
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the containers for vehicles market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the containers for vehicles market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coalitions and agreements to develop effective treatment on hepatitis C virus. In future, the growth of HCV market is expected to come from emerging markets of Asia Pacific, Middle East, and Latin America as these regions are likely to register maximum number of HCV incidences due to increasing...
Gasoline-Naphtha-Crude-MTBE Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Gasoline naphtha crude MTBE market is in growing demand in developing economies as these countries are focusing on economic development rather than environmental pollution. Asian market offers enormous growth opportunities for the MTBE industry. Gasoline-naphtha-crude-MTBE market is expected to witness an increase in MTBE consumption in the coming years in the Asian market.  MTBE (methyl tertiary butyl ether) is a flammable, volatile, and colorless liquid sparingly soluble in water and has minty odor of diethyl ether that adds unpleasant taste. MTBE is a gasoline additive...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Motor Co.s Shares Suffer Downfall as Lower Profit Outlook for 2014-2015 Surface
Oct 1, 2014  
Suffering from higher recall costs in its North American market and great losses in South America and Russia have made Ford motor Co. to cut-down its forecast regarding pretax profit this year to $6 billion from $7 billion to $8 billion as earlier mentioned.  Company’s CFO Bob Shanks said that company’s pretax profit in 2015 is expected to rise between $8.5 and $9.5...
Evereadys Kenya Plant to be Shut Down
Sep 30, 2014  
The largest dry-cell battery manufacturer in the region of East Africa, Eveready East Africa Ltd. intends on shutting down its one and only factory in Kenya on the 1st of October 2014. A real estate business will be started in its place. According to the Managing Director of Eveready East Africa Ltd. the plan of shutting down the plant was initiated by the board members of this company...
Sale of Apples iPhones Remains Unaffected - Supported By Consumer Feedback
Sep 29, 2014  
iPhones have been reintroduced in the global market by Apple Inc. in about 22 countries. Consumer reports and feedback basically show that due to the presence of a problem-free backing and update, these handsets are sturdy and do not bend easily. It has been observed via stress tests conducted on iPhone 6 and 6 Plus, that it requires high force and pressure to cause damage to these...
New Malware Targets Pharma Servers
Sep 29, 2014  
The electronics and communication agency Beldon has reportedly spotted a new cyber threat to the pharmaceutical industry. Called Dragonfly, the malware specifically targets intellectual property of servers in the pharmaceutical industry with the purpose of stealing information. An initial report released by ipprolifesciences.com stated the malware was targeting the energy sector....
Child’s Success Depends on Father’s Education Level: Study
Sep 24, 2014  
A father’s level of education is the strongest attribute that can determine a child’s success in academics, according to a research conducted in Britain. It also says that there is a self-reinforcing cycle of lack of achievement and poverty that is handed down from parent to child. The report was released by the Office for National Statistics and states that children are...